A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver.

[1]  A. Bradley,et al.  Structure and mechanism of monoclonal antibody binding to the junctional epitope of Plasmodium falciparum circumsporozoite protein , 2020, PLoS pathogens.

[2]  R. Gottardo,et al.  Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein , 2020, Malaria Journal.

[3]  C. King,et al.  Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages , 2019, Malaria Journal.

[4]  Kohske Takahashi,et al.  Welcome to the Tidyverse , 2019, J. Open Source Softw..

[5]  H. Wardemann,et al.  Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs , 2019, Nature Medicine.

[6]  H. Wardemann,et al.  Antibodies against Plasmodium falciparum malaria at the molecular level , 2019, Nature Reviews Immunology.

[7]  P. Sinnis,et al.  Antibody-Mediated Protection against Plasmodium Sporozoites Begins at the Dermal Inoculation Site , 2018, mBio.

[8]  S. Thiberge,et al.  Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin , 2018, Nature Microbiology.

[9]  R. Seder,et al.  Malaria prevention: from immunological concepts to effective vaccines and protective antibodies , 2018, Nature Immunology.

[10]  I. Wilson,et al.  Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts , 2018, Science Advances.

[11]  S. Hoffman,et al.  Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope , 2018, Science.

[12]  J. Julien,et al.  Peek-Peak-Pique: Repeating Motifs of Subtle Variance Are Targets for Potent Malaria Antibodies. , 2018, Immunity.

[13]  Erika L. Flannery,et al.  Plasmodium falciparum Liver Stage Infection and Transition to Stable Blood Stage Infection in Liver-Humanized and Blood-Humanized FRGN KO Mice Enables Testing of Blood Stage Inhibitory Antibodies (Reticulocyte-Binding Protein Homolog 5) In Vivo , 2018, Front. Immunol..

[14]  S. Hoffman,et al.  A public antibody lineage that potently inhibits malaria infection by dual binding to the circumsporozoite protein , 2018, Nature Medicine.

[15]  Alex B. Miller,et al.  A human monoclonal antibody prevents malaria infection and defines a new site of vulnerability on Plasmodium falciparum circumsporozoite protein , 2018, Nature Medicine.

[16]  S. Hoffman,et al.  Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection , 2018, The Journal of experimental medicine.

[17]  S. Kappe,et al.  Natural Parasite Exposure Induces Protective Human Anti‐Malarial Antibodies , 2017, Immunity.

[18]  C. Janse,et al.  An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens , 2017, Scientific Reports.

[19]  I. Wilson,et al.  Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein , 2017, Proceedings of the National Academy of Sciences.

[20]  Lu Zhang,et al.  Massively parallel de novo protein design for targeted therapeutics , 2017, Nature.

[21]  P. V. van Genderen,et al.  Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers , 2017, Science Translational Medicine.

[22]  F. Frischknecht,et al.  Plasmodium Sporozoite Biology. , 2017, Cold Spring Harbor perspectives in medicine.

[23]  D. Christensen,et al.  Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection , 2017, npj Vaccines.

[24]  D. Christensen,et al.  Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection , 2017, npj Vaccines.

[25]  J. Whisstock,et al.  Cell Traversal Activity Is Important for Plasmodium falciparum Liver Infection in Humanized Mice. , 2017, Cell reports.

[26]  V. V. Ganusov,et al.  Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in the hepatic sinusoids , 2017, Science Immunology.

[27]  Mario Roederer,et al.  Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection , 2017, Proceedings of the National Academy of Sciences.

[28]  C. Wilke.  Streamlined Plot Theme and Plot Annotations for 'ggplot2' , 2015 .

[29]  Kwaku Poku Asante,et al.  Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial , 2015 .

[30]  Yuming Guo,et al.  The effect of air pollution on human physiological function in China: a longitudinal study , 2015, The Lancet.

[31]  Lirong Shi,et al.  Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies. , 2015, The Journal of infectious diseases.

[32]  S. C. T. P. Rts.  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial , 2015, The Lancet.

[33]  Peter G. Kremsner,et al.  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. , 2015 .

[34]  Kwaku Poku Asante,et al.  A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine , 2014, BMC Medicine.

[35]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[36]  G. van Gemert,et al.  Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice , 2013, Malaria Journal.

[37]  Mario Roederer,et al.  Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine , 2013, Science.

[38]  S. Thiberge,et al.  Role of host cell traversal by the malaria sporozoite during liver infection , 2013, The Journal of experimental medicine.

[39]  Kwaku Poku Asante,et al.  Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data , 2013, The Lancet. Infectious diseases.

[40]  A. Vaughan,et al.  A rapid and scalable density gradient purification method for Plasmodium sporozoites , 2012, Malaria Journal.

[41]  M. Hollingshead,et al.  Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts , 2011, BMC biotechnology.

[42]  K. Marsh,et al.  Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial , 2011, The Lancet. Infectious diseases.

[43]  David Firth,et al.  Bias reduction in exponential family nonlinear models , 2009 .

[44]  V. A. Stewart,et al.  Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. , 2009, The Journal of infectious diseases.

[45]  A. Jin,et al.  Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate* , 2009, The Journal of Biological Chemistry.

[46]  Kurt Hornik,et al.  Implementing a Class of Permutation Tests: The coin Package , 2008 .

[47]  M. Prevost,et al.  Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. , 2008, Cell host & microbe.

[48]  C. Pipper,et al.  [''R"--project for statistical computing]. , 2008, Ugeskrift for laeger.

[49]  John A. Robinson,et al.  Crystal structure of an NPNA-repeat motif from the circumsporozoite protein of the malaria parasite Plasmodium falciparum. , 2006, Chemical communications.

[50]  J. Sattabongkot,et al.  Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. , 2006, The American journal of tropical medicine and hygiene.

[51]  U. Frevert,et al.  Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes. , 2004, International journal for parasitology.

[52]  M. Sällberg,et al.  A Malaria Vaccine Candidate Based on a Hepatitis B Virus Core Platform , 2003, Intervirology.

[53]  A. Holder,et al.  Function of Region I and II Adhesive Motifs ofPlasmodium falciparum Circumsporozoite Protein in Sporozoite Motility and Infectivity* , 2002, The Journal of Biological Chemistry.

[54]  L. Miller,et al.  Malaria: A sporozoite runs through it , 2001, Current Biology.

[55]  M. Mota,et al.  Migration of Plasmodium sporozoites through cells before infection. , 2001, Science.

[56]  J. Vanderberg,et al.  Delayed migration of Plasmodium sporozoites from the mosquito bite site to the blood. , 1997, The American journal of tropical medicine and hygiene.

[57]  Joe D. Cohen,et al.  A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. , 1997, The New England journal of medicine.

[58]  V. Nussenzweig,et al.  The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of plasmodium falciparum sporozoites , 1992, Cell.

[59]  R. Lerner,et al.  Conformational preferences of synthetic peptides derived from the immunodominant site of the circumsporozoite protein of Plasmodium falciparum by 1H NMR. , 1990, Biochemistry.

[60]  J. Verhave,et al.  The biotin‐streptavidin system in a two‐site ELISA for the detection of plasmodial sporozoite antigen in mosquitoes , 1988, Parasite immunology.

[61]  V. Nussenzweig,et al.  Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes , 1983, The Journal of experimental medicine.

[62]  J. Vanderberg,et al.  Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei , 1967, Nature.

[63]  G. Andrew,et al.  arm: Data Analysis Using Regression and Multilevel/Hierarchical Models , 2014 .

[64]  H. Delemarre-van de Waal,et al.  [A 2d patient with tropical malaria contracted in a natural way in the Netherlands]. , 1981, Nederlands tijdschrift voor geneeskunde.

[65]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[66]  J. Vanderberg,et al.  Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites. , 1969, Military medicine.